Filippi M, Bar-Or A, Piehl F, Preziosa P, Solari A, Vukusic S, et al
There are now three GLP-1RA drugs approved in multiple countries [see Table 1] for chronic weight management, all of which are administered as injections: Wegovy (active substance semaglutide) and Saxenda (active substance liraglutide) from Novo Nordisk, and Mounjaro/Zepbound 1 (active substance tirzepatide) from Eli Lilly the latter being the first dual receptor agonist 2 drug approved
No one ate them
Local peptide therapy providers familiar with insurance processes can help structure appeals for maximum approval probability
[DOI] [PMC free article] [PubMed] [Google Scholar] 91.Cava E., Yeat N.C., Mittendorfer B
Can GLP-1 analogues be used with insulin for diabetes management